Past exam of the biochemistry course of the University of Cambridge / 2024 / Paper 2 / Section I / 2

TFx induction makes it a candidate regulator, not yet a cause of neuronal differentiation. I would test when and where it acts, whether it is necessary or sufficient for a specific developmental transition, and which directly regulated genes explain the phenotype. The initial time-course result could instead reflect increasing neuronal abundance, selective survival, a response to differentiation, or expression of an inactive isoform.

First validate the observation in independent differentiations using quantitative RNA measurements and a specificity-validated protein assay. Examine transcript isoforms, protein abundance and nuclear localization over time, comparing neural precursors, differentiating neurons and other biological cell populations. single-cell RNA sequencing combined with imaging can determine whether TFx increases within a lineage or merely marks a population that becomes more common. Actual sampling times and lineage labels should anchor the analysis: a pseudotime ordering alone does not establish chronology or ancestry. Use independent donors or clones and differentiation batches as biological replicates, while tracking biological cell number, proliferation and apoptosis. A bulk increase caused by loss of another population is different from TFx activation within surviving precursors.

For necessity, reduce TFx using at least two independent perturbations, for example CRISPR interference and an independent guide or RNA interference reagent, or generate a verified gene knockout where viable. Rescue with a perturbation-resistant TFx expressed near its normal level. An inducible degron would provide faster and more sharply timed protein depletion than waiting for an existing pool to disappear after transcriptional inhibition. Perturb before commitment, during neuronal maturation and after maturation, using matched induction controls. A defect confined to the early window suggests a role in commitment; a late defect could instead concern maturation or maintenance. Constitutive loss followed by a late endpoint cannot distinguish these possibilities and can select compensatory biological cells.

The readout must define the affected transition. Count precursor and neuronal states, measure cell-cycle exit, neurite architecture and subtype markers, and assess mature physiology with patch-clamp recording and synaptic assays where appropriate. A marker-positive biological cell is not necessarily a functional neuron. Measure survival alongside fate: fewer neurons after TFx depletion could arise because neurons die rather than because precursors fail to differentiate. Track labelled starting biological cells through the transition and compare proportions as well as absolute output. If TFx changes only a particular neuronal subtype, a generic pan-neuronal assay could miss or misclassify its function.

For sufficiency, induce TFx at controlled levels in competent precursors under subthreshold differentiation conditions, and test whether it accelerates or redirects the transition. Include an empty-vector control, a DNA-binding-defective TFx variant and, if the domain architecture permits, a transcriptional-effector-defective variant. Test a second cellular context rather than assuming that all biological cells possess the required cofactors. Defined transcription-factor combinations can convert mouse fibroblasts into functional neurons, as demonstrated by Thomas Vierbuchen and colleagues, but this is an experimental precedent rather than evidence that the unspecified TFx is one of those factors.^[ref] Failure of TFx alone to induce neurons would not exclude an essential combinatorial role; strong overexpression could also create an activity absent at endogenous levels.

Next identify the direct regulatory programme. Map TFx-associated DNA with an endogenous epitope tag and CUT&RUN or chromatin immunoprecipitation, validating antibody specificity against TFx-depleted biological cells and including appropriate background controls. The targeted nuclease strategy underlying CUT&RUN provides a route to map protein-associated genomic regions at low background.^[ref] Combine binding with short-interval nascent-RNA measurements after acute TFx removal, before a large fate or survival shift occurs. Occupancy plus an early expression response prioritizes direct candidates; binding alone does not prove regulation, and a response without detected binding may be indirect or reflect an undetected distal site.

ATAC-seq before and after perturbation can test whether TFx changes accessibility, while histone-mark measurements and cofactor interaction assays refine the mechanism. Work on ASCL1 reprogramming showed hierarchical factor action and context-dependent chromatin engagement, motivating tests of whether TFx acts as a pioneer transcription factor or requires already accessible DNA.^[ref] Increased accessibility after TFx expression alone does not prove direct opening; first establish binding and an early response at that locus.

Finally edit a candidate TFx-binding motif at an endogenous enhancer, quantify target expression and differentiation, and compare with a matched neutral edit. Rescue a TFx-loss phenotype with the proposed downstream target or programme, while testing whether that target is required for TFx-induced differentiation. Such genetic ordering connects a molecular target to the biological effect; a plasmid reporter alone omits the native chromatin context. A justified conclusion would specify the transition, biological cell type, timing and direct targets supported by perturbation and rescue, while distinguishing differentiation from survival and maturation.